Global Clinical Biomarker Testing Market Size, Status and Forecast 2024-2034
Global Clinical Biomarker Testing Scope and Market Size
Clinical Biomarker Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Clinical Biomarker Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Cancer
Metabolism
Infectious Disease
Cardiology
Neurology
Immunological Disease
Segment by Application
Drug Discovery
Nutrigenomics
Toxicology Testing
Personalized Medicine
Functional Genomics
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott Laboratories
AbbVie Inc.
Adaptive Biotechnologies
Agilent Technologies
BD
Becton Dickinson
Bio-Rad Laboratories
Danaher Corporation
Merck and Co.
Thermofisher Scientific

Table of Content
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical Biomarker Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Cancer
1.2.3 Metabolism
1.2.4 Infectious Disease
1.2.5 Cardiology
1.2.6 Neurology
1.2.7 Immunological Disease
1.3 Market by Application
1.3.1 Global Clinical Biomarker Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Drug Discovery
1.3.3 Nutrigenomics
1.3.4 Toxicology Testing
1.3.5 Personalized Medicine
1.3.6 Functional Genomics
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Clinical Biomarker Testing Market Perspective (2016-2027)
2.2 Clinical Biomarker Testing Growth Trends by Regions
2.2.1 Clinical Biomarker Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Clinical Biomarker Testing Historic Market Share by Regions (2016-2021)
2.2.3 Clinical Biomarker Testing Forecasted Market Size by Regions (2022-2027)
2.3 Clinical Biomarker Testing Industry Dynamic
2.3.1 Clinical Biomarker Testing Market Trends
2.3.2 Clinical Biomarker Testing Market Drivers
2.3.3 Clinical Biomarker Testing Market Challenges
2.3.4 Clinical Biomarker Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Clinical Biomarker Testing Players by Revenue
3.1.1 Global Top Clinical Biomarker Testing Players by Revenue (2016-2021)
3.1.2 Global Clinical Biomarker Testing Revenue Market Share by Players (2016-2021)
3.2 Global Clinical Biomarker Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Clinical Biomarker Testing Revenue
3.4 Global Clinical Biomarker Testing Market Concentration Ratio
3.4.1 Global Clinical Biomarker Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Biomarker Testing Revenue in 2020
3.5 Clinical Biomarker Testing Key Players Head office and Area Served
3.6 Key Players Clinical Biomarker Testing Product Solution and Service
3.7 Date of Enter into Clinical Biomarker Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical Biomarker Testing Breakdown Data by Type
4.1 Global Clinical Biomarker Testing Historic Market Size by Type (2016-2021)
4.2 Global Clinical Biomarker Testing Forecasted Market Size by Type (2022-2027)
5 Clinical Biomarker Testing Breakdown Data by Application
5.1 Global Clinical Biomarker Testing Historic Market Size by Application (2016-2021)
5.2 Global Clinical Biomarker Testing Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Clinical Biomarker Testing Market Size (2016-2027)
6.2 North America Clinical Biomarker Testing Market Size by Type
6.2.1 North America Clinical Biomarker Testing Market Size by Type (2016-2021)
6.2.2 North America Clinical Biomarker Testing Market Size by Type (2022-2027)
6.2.3 North America Clinical Biomarker Testing Market Size by Type (2016-2027)
6.3 North America Clinical Biomarker Testing Market Size by Application
6.3.1 North America Clinical Biomarker Testing Market Size by Application (2016-2021)
6.3.2 North America Clinical Biomarker Testing Market Size by Application (2022-2027)
6.3.3 North America Clinical Biomarker Testing Market Size by Application (2016-2027)
6.4 North America Clinical Biomarker Testing Market Size by Country
6.4.1 North America Clinical Biomarker Testing Market Size by Country (2016-2021)
6.4.2 North America Clinical Biomarker Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Clinical Biomarker Testing Market Size (2016-2027)
7.2 Europe Clinical Biomarker Testing Market Size by Type
7.2.1 Europe Clinical Biomarker Testing Market Size by Type (2016-2021)
7.2.2 Europe Clinical Biomarker Testing Market Size by Type (2022-2027)
7.2.3 Europe Clinical Biomarker Testing Market Size by Type (2016-2027)
7.3 Europe Clinical Biomarker Testing Market Size by Application
7.3.1 Europe Clinical Biomarker Testing Market Size by Application (2016-2021)
7.3.2 Europe Clinical Biomarker Testing Market Size by Application (2022-2027)
7.3.3 Europe Clinical Biomarker Testing Market Size by Application (2016-2027)
7.4 Europe Clinical Biomarker Testing Market Size by Country
7.4.1 Europe Clinical Biomarker Testing Market Size by Country (2016-2021)
7.4.2 Europe Clinical Biomarker Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Clinical Biomarker Testing Market Size (2016-2027)
8.2 Asia-Pacific Clinical Biomarker Testing Market Size by Type
8.2.1 Asia-Pacific Clinical Biomarker Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Clinical Biomarker Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Clinical Biomarker Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific Clinical Biomarker Testing Market Size by Application
8.3.1 Asia-Pacific Clinical Biomarker Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Clinical Biomarker Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Clinical Biomarker Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Clinical Biomarker Testing Market Size by Region
8.4.1 Asia-Pacific Clinical Biomarker Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Clinical Biomarker Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Clinical Biomarker Testing Market Size (2016-2027)
9.2 Latin America Clinical Biomarker Testing Market Size by Type
9.2.1 Latin America Clinical Biomarker Testing Market Size by Type (2016-2021)
9.2.2 Latin America Clinical Biomarker Testing Market Size by Type (2022-2027)
9.2.3 Latin America Clinical Biomarker Testing Market Size by Type (2016-2027)
9.3 Latin America Clinical Biomarker Testing Market Size by Application
9.3.1 Latin America Clinical Biomarker Testing Market Size by Application (2016-2021)
9.3.2 Latin America Clinical Biomarker Testing Market Size by Application (2022-2027)
9.3.3 Latin America Clinical Biomarker Testing Market Size by Application (2016-2027)
9.4 Latin America Clinical Biomarker Testing Market Size by Country
9.4.1 Latin America Clinical Biomarker Testing Market Size by Country (2016-2021)
9.4.2 Latin America Clinical Biomarker Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Clinical Biomarker Testing Market Size (2016-2027)
10.2 Middle East & Africa Clinical Biomarker Testing Market Size by Type
10.2.1 Middle East & Africa Clinical Biomarker Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Clinical Biomarker Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Clinical Biomarker Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa Clinical Biomarker Testing Market Size by Application
10.3.1 Middle East & Africa Clinical Biomarker Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Clinical Biomarker Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Clinical Biomarker Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Clinical Biomarker Testing Market Size by Country
10.4.1 Middle East & Africa Clinical Biomarker Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Clinical Biomarker Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Clinical Biomarker Testing Introduction
11.1.4 Abbott Laboratories Revenue in Clinical Biomarker Testing Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 AbbVie Inc.
11.2.1 AbbVie Inc. Company Details
11.2.2 AbbVie Inc. Business Overview
11.2.3 AbbVie Inc. Clinical Biomarker Testing Introduction
11.2.4 AbbVie Inc. Revenue in Clinical Biomarker Testing Business (2016-2021)
11.2.5 AbbVie Inc. Recent Development
11.3 Adaptive Biotechnologies
11.3.1 Adaptive Biotechnologies Company Details
11.3.2 Adaptive Biotechnologies Business Overview
11.3.3 Adaptive Biotechnologies Clinical Biomarker Testing Introduction
11.3.4 Adaptive Biotechnologies Revenue in Clinical Biomarker Testing Business (2016-2021)
11.3.5 Adaptive Biotechnologies Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Details
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies Clinical Biomarker Testing Introduction
11.4.4 Agilent Technologies Revenue in Clinical Biomarker Testing Business (2016-2021)
11.4.5 Agilent Technologies Recent Development
11.5 BD
11.5.1 BD Company Details
11.5.2 BD Business Overview
11.5.3 BD Clinical Biomarker Testing Introduction
11.5.4 BD Revenue in Clinical Biomarker Testing Business (2016-2021)
11.5.5 BD Recent Development
11.6 Becton Dickinson
11.6.1 Becton Dickinson Company Details
11.6.2 Becton Dickinson Business Overview
11.6.3 Becton Dickinson Clinical Biomarker Testing Introduction
11.6.4 Becton Dickinson Revenue in Clinical Biomarker Testing Business (2016-2021)
11.6.5 Becton Dickinson Recent Development
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Details
11.7.2 Bio-Rad Laboratories Business Overview
11.7.3 Bio-Rad Laboratories Clinical Biomarker Testing Introduction
11.7.4 Bio-Rad Laboratories Revenue in Clinical Biomarker Testing Business (2016-2021)
11.7.5 Bio-Rad Laboratories Recent Development
11.8 Danaher Corporation
11.8.1 Danaher Corporation Company Details
11.8.2 Danaher Corporation Business Overview
11.8.3 Danaher Corporation Clinical Biomarker Testing Introduction
11.8.4 Danaher Corporation Revenue in Clinical Biomarker Testing Business (2016-2021)
11.8.5 Danaher Corporation Recent Development
11.9 Merck and Co.
11.9.1 Merck and Co. Company Details
11.9.2 Merck and Co. Business Overview
11.9.3 Merck and Co. Clinical Biomarker Testing Introduction
11.9.4 Merck and Co. Revenue in Clinical Biomarker Testing Business (2016-2021)
11.9.5 Merck and Co. Recent Development
11.10 Thermofisher Scientific
11.10.1 Thermofisher Scientific Company Details
11.10.2 Thermofisher Scientific Business Overview
11.10.3 Thermofisher Scientific Clinical Biomarker Testing Introduction
11.10.4 Thermofisher Scientific Revenue in Clinical Biomarker Testing Business (2016-2021)
11.10.5 Thermofisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details